Avelumab

Description

BAVENCIO (avelumab) is a prescription monoclonal antibody used in immunotherapy to treat certain cancers by blocking PD-L1, helping the immune system fight tumor cells. It's given as an intravenous infusion at a strength of 20 mg/mL. This information was generated using AI and is provided for informational and research purposes only.

Resources

Name Format Description Link
21 Access the FDA dataset for Avelumab — ANDA 761049 submitted by Mylan Institutional LLC https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761049

Tags

  • fda
  • drug-safety
  • health-care
  • prescription-drugs
  • pharmaceuticals

Topics

Categories